Safety and efficacy of immune checkpoint inhibitors in patients with HBV/HCV infection and advanced-stage cancer
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference46 articles.
1. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study;Lancet Gastroenterol Hepatol,2018
2. Global epidemiology and genotype distribution of the hepatitis C virus infection;Gower;J Hepatol,2014
3. Hepatitis B virus reactivation and prophylaxis during solid tumor chemotherapy: a systematic review and meta-analysis;Paul;Ann Intern Med,2016
4. Hepatitis C virus reactivation in cancer patients in the era of targeted therapies;Yazici;World J Gastroenterol,2014
5. [Hepatitis B virus reactivation in rituximab-treated patients: incidence and risk factors];Gutierrez Garcia;Gastroenterol Hepatol,2015
Cited by 67 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immune checkpoint inhibitors in infectious disease;Immunological Reviews;2024-09-09
2. Hepatobiliary complications of immune checkpoint inhibitors in cancer;Exploration of Targeted Anti-tumor Therapy;2024-07-26
3. Tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for hepatocellular carcinoma: recent research progress;Frontiers in Pharmacology;2024-06-18
4. Safety of nivolumab monotherapy in five cancer types: pooled analysis of post-marketing surveillance in Japan;International Journal of Clinical Oncology;2024-06-06
5. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU;Gastroenterología y Hepatología;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3